PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28433514-7	2017	Interestingly, recruitment of CD4+T cells and F4/80+ macrophages as well as BMSC transplantation induced up-regulation of Cox-2 and IL-17A gene expression levels were reverted by celecoxib administration.	Celecoxib	179-188	interleukin 17A	Mus musculus	132-138	
28433514-9	2017	Conditioned media of rIL-17 treated J774.2 cells when supplemented to BMSCs depicted a dose-dependent increase in the number of apoptotic cells and proapoptotic protein expression that was perturbed by celecoxib or IL-17 neutralizing antibody.	Celecoxib	202-211	interleukin 17A	Mus musculus	22-27	
28433514-11	2017	CONCLUSION: Celecoxib protects transplanted BMSCs from Cox-2/IL-17-induced inflammation and increases their engraftment, differentiation into keratinocytes and re-epithelialization thereby potentiating wound tissue repair.	Celecoxib	12-21	interleukin 17A	Mus musculus	61-66